ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000138.1|Rimocidin_2 # 2006 # 3133 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000138.1|Rimocidin_2 	2006	3133	-	Loose	175	28.4906	vanT gene in vanG cluster	43.75	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAACTCACCATCCACGGCGGCCGTGCAGACCGCCCGCCGCATCGCCGTGTCGTTCGTCGCCACCGTTTCGGCCGTGGGGGTCACCGCGTCCTTCGCCTCGGCCGAGCCCGTCGCCGCGCCGCACACCGAAGCGGGACGGCACGCGGCGCAGGCGCCGCGTGCCACGCGCGGGATTCCGTTCACCCAGGCCACGGTGGCCCGACAGCAGGACGGTTCCTTCACCGTGTCCTGGAAAGCGCCCGGCGCCGGTTCCGTGACCGTCTACGCCGACGGCAAGGTCGTGGCATACGGCGGGGCCGAGGCCACCATCACCGTACGCCGGCTGCCCGCGGCCGACCGTCAGTGGTTCCGCCTCGTGCCGGACGAGGGCGACCCGCTCACCCTCGCCGACCGCTCGCTGCACCTGGAGGGCGCCGCCAACTTCCGTGACGTGGGCGGCTACCGAACCGCCGACGGCCGGTGGGTGAAGATGGGCGTGCTGTACCGCTCGCCGACGCCCTGCACAAGCTCACCGACGCCGACCTGGATCAAGCTGCGGCGCCTGGGCATCCGTACGGACTTCGACCTGCGCACGCCGGGCGAGCGGGCCAAGGCCCCGGACCGGGTACCGGCGGGCGCACGCTATGTCGTCGCCAATGTCATCGGCGAGGAGAACTCCGCCGAACTGCCCCCCACGGCGGAGGCGTCCGAGCGGCTGATGGCCGAATCCTACCGGCAGTTCGTCGTCAGGCCCTCGGCCGCCAAGGCTTACCGTTCGCTGTTCCGCATGGCCGCCGAGCCCGGCTCGTACCCGCTGCTCTATCACTGCTCCAGCGGCAAGGACCGCACGGGCTGGGCGACGGCCGTCCTCCTCACGGCCCTCGGCGTGGACCGCGAGACGGTCATGCGCGACTACCTGGCCAGCAACGACTATCTCGCCGCAAGCAACGCCGCCGAACTGGCCAAGCAGCCGCCCGAGATCGCCGCCCGCCTCAAGCCGGTCCTGGAGACCAGGGCCCCGTACCTGAACGCCGCCTTCGACGAGGTCGAGGCGCGCTTCGGCACCTTCGGCGCCTATCTGCGGGAGGGGCTGGGGCTGAACGCGCAGGAGCTGGAGCGGCTGCGGGCGGCGCTGCTCACCGACTGA	MNSPSTAAVQTARRIAVSFVATVSAVGVTASFASAEPVAAPHTEAGRHAAQAPRATRGIPFTQATVARQQDGSFTVSWKAPGAGSVTVYADGKVVAYGGAEATITVRRLPAADRQWFRLVPDEGDPLTLADRSLHLEGAANFRDVGGYRTADGRWVKMGVLYRSPTPCTSSPTPTWIKLRRLGIRTDFDLRTPGERAKAPDRVPAGARYVVANVIGEENSAELPPTAEASERLMAESYRQFVVRPSAAKAYRSLFRMAAEPGSYPLLYHCSSGKDRTGWATAVLLTALGVDRETVMRDYLASNDYLAASNAAELAKQPPEIAARLKPVLETRAPYLNAAFDEVEARFGTFGAYLREGLGLNAQELERLRAALLTD	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	52.67	gnl|BL_ORD_ID|1522|hsp_num:0	1561			921	1017	vancomycin
BGC0000138.1|Rimocidin_4 # 5254 # 6636 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.670	BGC0000138.1|Rimocidin_4 	5254	6636	+	Loose	700	51.2174	oleD	30.08	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGAATCCGCCCGACGGCCGATCCTCTTCGTCAGTCTTCCGGAGGCCGGGCTGGCCAATCCGCTGCTCGTCCTGGCCGAGGAACTCTCCCGCCAAGACGTGCCGGATCTCTGGTTCGCCACCGACGAGCCGCGGCGCGAGGACGTGAAGAAGATTTCGGTGGGGTCTCCGGTGGAATTCGCCTCACTGGGCGAGGTGGTCCCCGAACTGTCGGCCGTGACCTGGGGCGACGAGGTGTACCGGGAAGTCACCCAGTCGTCGCGGTTCAAGGCGCACCGCGCGGTGATCCGGCACTCGTACGTGCCCCGCGCGCAGGAGGAGAAGTTCCAGAAGCTCGCGGCCGTCGTCGACGAGATCCGGCCGGCGCTGATCGTCGTCGACTGCATCAGTTCGTACGGCGTGGAGCTGGCCATGGCGCGGAAGATCCCGTACGTGCTCAGCGTGCCGTTCACCCCGAGCAATGTGCTGACGGCGTTCACCCCCTTCGCCAAGGGCTACACCCCGAAGGACTTCCCCGTACCGCACACGGGGCTGCCCTATCCGATGAATCTCCCGCAGCGGGTGCGCAACATGCTCTTCAAACTGCGGACCCTCGCGATGTTCTGCAACCCCACGATGAGCAAGGTACTGGCCGAGGACAACCGGCGGCGCAAGGCGCACGGGCTCGGGCAGATGAGCCCGATGGCGCGGATCGACCACGCCGATCTGGTGCTGTGCAATTCCATCGCCGAGCTGGACTATCCCTTCGACATTCCGGAGAAGTTCCGGATGGTCGGCACGATGGTGCCGCCCCTGCCGGAGGCGGAGCAGGAGGACGAGCTCTCGCGGTGGCTGGACGAACAGCCCTCGGTCGTCTACGCGGGATTCGGAACCATCACCCGGCTCACCCGGGAACAGGTCCATTCCATGGTCGAGGTGGCCCGCCGGCTCCAGGGGCGGCACCAGGTGCTGTGGAAACTGCCCTCGGGACAGCAGCACCTGCTGCCGCCGAAGGAATCCCTGCCGGACAATCTCCGTATCGAGAACTGGGTCCCTTCGCAGCTCGATGTCCTCGCGCATCCGAACGTGAAGCTGTTCTTCACCCACGCCGGCGGCAACGGCTACAACGAAGGCGTGTATTTCGGCAAGCCGCTCGTGGTACGGCCGCTGTGGGTGGACTGCTACGACCAGGCCGTACGCGGCCGGGATTTCGGCATCAGCCTGACCCTCGACCGGCCCCGGGACCTCGATGTCGACGACGTCGTCGACAAGCTGACCCGAGTGCTCGAAACCCCCTCCTTCCGCGAGAACGCGGAGCGGCTCGGCGCCCTGCAGCGTGCGGCGGGCGGCCGTGCGGCCGCTGCCGAGGTGATCCTCGGACACCCGGCCCTGGCCCGGGCGTAA	MESARRPILFVSLPEAGLANPLLVLAEELSRQDVPDLWFATDEPRREDVKKISVGSPVEFASLGEVVPELSAVTWGDEVYREVTQSSRFKAHRAVIRHSYVPRAQEEKFQKLAAVVDEIRPALIVVDCISSYGVELAMARKIPYVLSVPFTPSNVLTAFTPFAKGYTPKDFPVPHTGLPYPMNLPQRVRNMLFKLRTLAMFCNPTMSKVLAEDNRRRKAHGLGQMSPMARIDHADLVLCNSIAELDYPFDIPEKFRMVGTMVPPLPEAEQEDELSRWLDEQPSVVYAGFGTITRLTREQVHSMVEVARRLQGRHQVLWKLPSGQQHLLPPKESLPDNLRIENWVPSQLDVLAHPNVKLFFTHAGGNGYNEGVYFGKPLVVRPLWVDCYDQAVRGRDFGISLTLDRPRDLDVDDVVDKLTRVLETPSFRENAERLGALQRAAGGRAAAAEVILGHPALARA	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	110.84	gnl|BL_ORD_ID|1253|hsp_num:0	1367			840	1182	erythromycin; tylosin
BGC0000138.1|Rimocidin_5 # 6690 # 7748 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.662	BGC0000138.1|Rimocidin_5 	6690	7748	+	Loose	750	26.5646	tet(49)	34.04	3004582	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTCGTTCAAGTATCCCGTGTCCAGGCCCGCTCTGGAGGGCAACGAGCTGGCGTATCTGACCGGTGCCGTCGAGGACGGGTGGATTTCCTCCCAGGGCCCGATGGTCGGGCGGTTCGAGCGTGCCTTCGCCGACTACAACGGCATCGCGCACGGCGTTTCCTGTTCCTCGGGAACGGCGGCGCTCACCCTCGCGCTGCGGGCGCTGGGCATCGGCCCGGGGGACGAGGTCATCGTCCCGGAATTCACGATGATCGCCTCGGCATGGGCGGTCACCTACACCGGCGCCACGCCCGTGTTCGTGGACTGCGGGGACGACCTCAACATCGACGTCACCCGTATCGAGGAGAAGATCACGGCGCGCACGAAGGCCGTGATGCCGGTGCACATCTACGGCCGGCGGTGCGACATGGACGCGATCATGGACATTGCGTACCAGTACAACCTGCGGGTCGTGGAGGACAGCGCCGAAGCGCACGGCATTCGGCCGGTCGGTGACATCGCGTGCTACTCGCTGTTCGCCAACAAAATCATCACGGCGGGGGAGGGCGGTATCTGCCTCACCGACGACCCGAAACTCGCCGGGCAGATGCAGCACTTGCGGGCCATGGCGTTCACCAAGGACCACAGTTTCCTGCACAAGAAGGTGGCGTACAACTACCGCATGACGGCCATGCAGGCCGCCGTCGCGCTCGCCCAGACCGAGCGCCTGGACGACATCCTCGAAGTGCGCCGCGGAATCGAGAAGCGCTACGACGAGGGGCTGGCCGATGTCCCCGGTATCACGCTGATGCCGCCGCGGGACGTGCTGTGGATGTACGACCTGCGCGCCGAACGCCGCGAGGAACTGCGGGAATTCCTGGCCGGGGAGTCCATCGAGACCCGGCTGTTCTTCAAGCCGATGAGCCGGCAGCCCATGTACTTCCACCCCGACTGGCCCTCGCTCAAGGCGAACACCTTCGCCGAGGACGGACTGTACCTGCCCACCCACACCGGACTGACCGCCGGCGACCAGGACTTCGTGATCGACCGGGTCCGCGCCTTCTACGGCGTCGGCTGA	MSFKYPVSRPALEGNELAYLTGAVEDGWISSQGPMVGRFERAFADYNGIAHGVSCSSGTAALTLALRALGIGPGDEVIVPEFTMIASAWAVTYTGATPVFVDCGDDLNIDVTRIEEKITARTKAVMPVHIYGRRCDMDAIMDIAYQYNLRVVEDSAEAHGIRPVGDIACYSLFANKIITAGEGGICLTDDPKLAGQMQHLRAMAFTKDHSFLHKKVAYNYRMTAMQAAVALAQTERLDDILEVRRGIEKRYDEGLADVPGITLMPPRDVLWMYDLRAERREELREFLAGESIETRLFFKPMSRQPMYFHPDWPSLKANTFAEDGLYLPTHTGLTAGDQDFVIDRVRAFYGVG	MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE	90.96	gnl|BL_ORD_ID|2695|hsp_num:0	3285			873	1005	tetracycline; oxytetracycline
BGC0000138.1|Rimocidin_6 # 7777 # 9039 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0000138.1|Rimocidin_6 	7777	9039	+	Loose	575	28.8758	AST-1	34.21	3004740	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	AST Beta-lactamase	ATGACGCACACCGAACCGGCCGCGCCGGCCACCTGCCCGGTCACGGGAGCGACGGCCGGGGCCACGGACACGACGGATTCGACCGGGCACGGAACGGACCCGCTGGTCGTCGACTTTCCGCTGCGCGCGCCCGGCATACCCTTCCCGCCGCCCGAATACGCCGATTACCGCGACAAGAAGGGGCTGGTGCTCTCGCACCTGCCCGACGGCAAACGGGTGTGGCTGGTCACCCGGCACGAGGACGTACGCGCCGTCCTGACCAACCCGGCCATCAGCTCCAACCCCCAGCACCCGGGCTTTCCCAATGTCGGCGAGACGATCGGCGTACCCAGGCAGGACCAGATACCCGGCTGGTTCGTGGGAATGGACTCGCCCGAACACGACCGGTTCCGCAAGGCCCTCATCCCGGAGTTCACCGTGCGGCGCGTCCGCGCGATGAAACCCGCGATCGAGCGCACGGTGGACGCGCAACTGGACGCGATGCTGGCCGCGGGCAACACCGCCGACCTCGTCGCCGACTTCACCCTGCCCATTCCCTCCCTGGTGATCTCGGCACTGCTCGGCGTGCCGCCCGCCGACCGCGAGTTCTTCGAATCCAGGACCCGCGTCCTGGTCTCGTTCCGTGCGTACTCCGACGAGGACCGCCTGGCCGCCGGCAAGGACCTCATGCGGTACATCAACCGGCTGATCGAGATCAAGAAGAACTGGGGCGGCGACGACATCGTCACCCGGCTGCTGGCCACCGGCGCCATCGGTGCCCACGAAATGTCCGGCGTACTGATGCTGCTGCTCATCGCCGGCCACGAGACCACGGCCAACAACATCGCGCTCGGTGTGGTCACCCTGCTGAAGAATCCCCAGTGGATCGGTGACGAACGGGCCGTCGAGGAAACCCTGCGCTTCCACTCGGTCGCCGACCTGGTGTCCCTGCGGGTGGCCGTCGAGGACGTGGAGATCGCCGGGCAGCACATCAAGGCGGGCGAGGGCATCGTGCCGCTGGTCGCCGCCGCCAATCACGACGAGGAACTCTTCGCGTGCCCCCACGCGTTCGACCCCTCCCGCTCCGCCCGCGGCCATGTGGCCTTCGGCTACGGCGTACACCAGTGCCTGGGGCAGAACCTGGTACGGGTCGAGATGGAGGTCGCGTACCGCAAGCTCTTCGAGCGCATTCCCAACCTCCGGCTCGACGTGCCCGAGGACGGACTGAACATCAAGTACGACGGCGTGCTCTACGGCCTGCACGAGCTGCCCGTCCGCTGGTGA	MTHTEPAAPATCPVTGATAGATDTTDSTGHGTDPLVVDFPLRAPGIPFPPPEYADYRDKKGLVLSHLPDGKRVWLVTRHEDVRAVLTNPAISSNPQHPGFPNVGETIGVPRQDQIPGWFVGMDSPEHDRFRKALIPEFTVRRVRAMKPAIERTVDAQLDAMLAAGNTADLVADFTLPIPSLVISALLGVPPADREFFESRTRVLVSFRAYSDEDRLAAGKDLMRYINRLIEIKKNWGGDDIVTRLLATGAIGAHEMSGVLMLLLIAGHETTANNIALGVVTLLKNPQWIGDERAVEETLRFHSVADLVSLRVAVEDVEIAGQHIKAGEGIVPLVAAANHDEELFACPHAFDPSRSARGHVAFGYGVHQCLGQNLVRVEMEVAYRKLFERIPNLRLDVPEDGLNIKYDGVLYGLHELPVRW	MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELETTSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSAAELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDATSRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGATRIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAEATRVVVDALG	135.48	gnl|BL_ORD_ID|2556|hsp_num:0	3555			645	756	
BGC0000138.1|Rimocidin_8 # 9400 # 14610 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000138.1|Rimocidin_8 	9400	14610	+	Loose	1000	51.2174	almE	23.84	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCCCGTCCACACAGCTGACTACGTGATCCAGCCGCCCACCGACGCGGCGGAGGTACGGGGCGGCCACACGCTGCCCGAGGTGTTCGAGACCGCGTCGAGGGCCGCCCCCGACGCGGTGGCCATCGTGGACGGGGACCGTTCGCGGACCTGGGCGCAGTGGCGGGCGGACGTCCGCGCGCTGGCCCGTGGCCTCCAGGAATCGGGCGTCGGGCCCGGTGACGTGGTGGCGGTGCGGCTGCCGAACAGCTGGGAGTTCCAGACCCTGCACCTGGCCGTCGCGGCCGTCGGCGCCGTACTGCTGCCCGTCCACGAGGGCACCCCGACCGCGGAGGTCCACGCGCTGCTGACCCGCGCGGAACCCGTACTCCTCGTCCTGTCGGCTTCCGGGAGCGAGGGCACGGCAACGGCCCGCTCGCTCCTGGAGAGCGTGCCGACGCTGCGCGGCGTGCTGCTGGCCGGGGCGTCGGAGGCGGAGTGCGAGGAGCCGGGGATCGGGGCGCTGGACGGGTTGCGGGCAGCCTGGACGGGCAGCGAGCCCCGGCCGGTGCACCTCACCCCCGACATGCCGCTCGCCCTGATCCCCTCGTCCGGCACCACCTCGGCGCGGCCCAAGCTGTGCGTGCACACCCACGGCGGCCTGCTGGCGAACACCGCGGCCGTCGTGGCCGATGCCGCCGACGCCTTCGGCGGCACGGTCCTGACCGCCTGCCCGATGACCCACCTGTTCGGGCTCCAGTCCCTGCACACGGCGCTGTTCGCCGCCCGGACGCAGGTCCTGCTCACCGGCTGGGACGTGGACCGCTTCCTGGAGCTGGCGCGGGAGCACAACCCCCGCGTCGTCTTCGCCGTACCCGCCCAACTGCGGGACATCGTCGCGCGACTCGCCAGGGCGGGCGAGCCGGCGGGCTTCGCGCCGCACCAGGTGCGTACGGCGGGCGCCGCCCTCGCACCCGCGCTCGCCGCACAGATACGCGCCGCCCTCGACTGCGAACCGGTCGTGGTGTGGGGCATGTCCGAGATCGGCACCGGCACCGCAACCCGGGCCCACCACCCCGACGGCAGCGTGGGAGAACCGGTCGACGGCGTGCGCGTACGGGTCGTCGACGAGCACGGCGCGGAGTGCGCGGCGGGGGAGACGGGCGAGCTCCAGTACCAGGGCCCGGCGATGTTCCGCGGCTATTTCCGCGAGCCGGAGCTGACGCGCTCGGCCCTCACCGACGACGGCTGGCTGCGGACCGGCGACATCGCCGCCATCGACGCGGACGGCGTGGTCGTCCTGCACGGCCGGGCGGCCGAAGTGATCGCCACCGGAGGCCGGAAGTTCGGCGCCACCGAAATCGAGAGCCTGCTCGCGGAGCTCGCGGGCCTGGGCCCGCTGGCCGTGGCGGGGGCGCCGGACGACCGGCTCGGCGAGTACCCGTGCCTGGTCGTGACCGACCGCGCGGACCGTACGATCGGGCTGACCGAGGTGACCGCGTTCCTGCGCCGGCGGGGACTCGCCGACCACAAGATCCCCCTCGAACTGGTCACCGTGCGCGAGCTGCCCTTCACCCCCGCGGGGAAGCTCGACCGCAGGGCACTCAAGGAGCAGCTGCGCACCGGCCTGGAAGCGACGCCCGTGGCGGCCCGTCTCGGCGCGGTCCCGCCGGAGACGGCCGAAGAGGCGCTGGAACTGGTACGCGACTGCGTCGGCCAGGTCCTCGGCAGCAGCGGCGACCCGGCCGGCCCCGCCGTCGGTGCGCCGGAATTCCCCGACACCGAATTCCGCCGGCTCGGCCTCGACTCCGTCCTCGCGGTGCGGCTGCGCAACCTGCTGCGGGAGGAGACCGGGCTGTCCCTCCCGGTCACGCTGGCCTTCGACTTCCCGACGCCGCGGGCCGTGGCGCACGCACTGGCCGAGCAGAACGACCCGGCTTCGGCGGCGGCATCGGGGAAGACGGCGGAGGAGGCGCGGAGGTTCCCGGCCGACGAGGCCGATCCGGTGGCGATCGTCGCCATGGCCTGCCGCCTGCCGGGCGGCGCCGACTCTCCCGACGCCCTGTGGGAGCTGCTGGCCGGCGGAACCGACGCGATGCGGCCCTTCCCGGACGACCGCGGCTGGGACCTGGACCGCCTCTTCGACGAGGACCCCGACCGGCCGGGCACCTGCTACGCACGCGAAGGCGGCTTCCTGCCCGGCGCGGGCGACTTCGACGCGGGCTTCTTCGGCCTGTCCGACCACGAGGCGACGGCCACCGACCCGCAGCAGCGCCTGCTCCTGGTGGCGGCCTGGGAGACCTTCGAGCGGGCGGGCATCGACCCGGCGTCCCTGAAGGGCACCCGTACGGGCGTGTTCACCGGCGCGATGGAGCGCGGCTACGGCGCTCTCGCGTCCGCCGTCCCCAGCGAGTGGGAGAGCACGCTCACCACCGGGGCCGCCAACAGCGCGATCTCCGGGCGCATCGCCTACACCTACGGCCTCGAAGGCCCCGCGCTGACCGTCGACACCGCCTCCTCGTCCTCCCTCGTCGCCCTGCACCTGGCCTGCCGCTCCCTGCGGTCGGGCGAGACCGACCTGGCGCTGGCCGGCGGCGTCACCGTCATGGCGACCCCGGCGCCCTTCACCCACTTCGCCCGGCTGCGCGCGCTCGCCACCGACTCGCGCGCCAAGGCGTACGCGGACACCGCGAACGGCTCCGCGTGGGCGGAAGGCGCGGGACTGCTGCTGCTGGAGCGGCTGAGCGACGCCCGCCGCAACGGACACCGTGTACTGGCGCTCGTACGGGGCTCGGCGGTCAACCAGGACGGCGCCTCCAACGGGCTCACCGCCCCGAGCGGCCCCGCGCAGCAGCGCGTCATCCGCCAGGCCCTGGCCGACGCCGGTCTGACGCCGCGGGACGTGGACGCGGTGGAGGGGCACGGCACCGGCACTCCGCTCGGCGACCCGATCGAGGCCCAGGCCCTGATGGCCACCTACGGCCAGGAGCGGCCGGAGGGACGGCCGCTGTGGCTGGGGTCGGTGAAGTCCAACCTCGGGCACACACAGGCCGCTGCCGGGGTCGTCGGGGTCATCAAGACGGTGCTCGCGCTGGGCCGCGGCGTCCTGCCCAGGACGCTGCACGTGGAGACTCCTTCCACCAAGGTCGACTGGTCCGCCGGGGCGGTACGGCTGCTGACCGAGGCGCAGCCCTGGCCCCAGGAGAGCGGGCACACGCGGCGGGCAGGAGTGTCGTCCTTCGGGCTCACCGGCACCAACGCCCACGTGATCCTGGAGGAGGCCCCGGACGGGACGCAGAGCGCGCCCGGATCGGAACCGGCCGACGACACCGCCGTACCGTGGGTGCTCTCCGCACGGAGCCGGACGGCGCTGCGCGAACAGGCCCGCCGCCTGGCCGAGCACGTGACCGCTCACCCCGGCCTGCGCACACAGGACATCGCCCACGCCCTGGCCACCACCCGCACCCGGCACCGGCACCGGGCCGTCGTCAGCGGCTCCGACCGGGACCGGATGCTGTCCGCGACGGCCGCGTTCGGGCGCGGGGAGCGGGCCGCGGACGTCACCCCGCTCGATTCCGCGCCGGGCGGCCTGGCCTTCGTCTTCTCCGGACAGGGCGGCCAGCACCCCGGCATGGGGCGCGGGGCGGCCGAGGCGTTCCCCGTGTTCGGGGAGGCGCTGCGCGAGGTGTGCGACACCCTCGACCCGCTGCTGGCACGTCCGCTGACCTCGGTGATGTGGGCGGACGCCGACTCCGAGGAGGCGACGCTGCTGCACAACGCCGAGTTCTCGCAGCCCTCGCTGTTCGCCCTCCAGGTCGCCCTCTACCGGCTGTACGAGTCCTGGGGCATGGCCCCGGACCGTCTCGCGGGCCATTCGGCCGGCGAGATCGCCGCCGCGCATGTCACCGGCATCCTCACCCTCCAGGACGCCTGCGCCCTGGTGGCCTCCCGGGGCAGGCTGATCAGCTCGCTGCCGGTCGGCGGCGCGACGGTGGCGGTGCGCATCTCGGAGGACGAGGTGCGGGGGTGGCTCGCCGAGGAGACGACCGGCTCGGTCTCGATCGCGGCCGTCAACGGGCCGCACTCCCTCGTACTCTCCGGTGCCGAGGCCCCGCTCATCGCCCTCACGGACCGGCTCCGCGACGCCGGCCACAAGACCCACCGCATCCCCATGAGGGTCGCGGCCCACTCACCGCTGATGGACCCCATCCTGGGGGAGTTCCGCGCGGTCGTCCGCACGCTGGCCTACGGCACGCCCACCATCCCCCTCGTCTCCACCGTCACCGGCCGCCCGCTGACCGACGAGGAGGCGCGCGACCCTGAGCACTGGGTACGGCACGTGCGGCGGCCCGTGCGCTTCAAGGACGCGATCGGCCGGCTCCGGGAGGAGCGCGTCACCGGCTTCCTGGAGCTGGGCGCCGAGCCGCTGCTCACCCCCATGATCGACGAGTGCCTGGAGGCGGCCGGCCCGCAGCACGGAACCGCCGTGGTGCCGAGCCTGAGCTCCGGCGTACCGGACCGGCAGATCCTGCTCTCCGCGGCCGCCCGGGTGCACACCCACGGCGCACCCGTCGACTGGGACGCGGTGCTGCCCGGGGCCCGGCCCGTCGACCTGCCGACGTACGCGTTCCAGCGGCGGCGGTTCTGGCTGGCGGCGGGGCCGGGTGCGGCCGCCGAGGCCGGTTTCGTGGGTGCCGCGATCGGCGCGGGCGCGCCGGCGGCCGATGCGGAGGAGCCGTCGGGCCTGGAAGCCCGGCTGGCCGGTCTCGAAGACGCCGAACAGGACGCGTACGTACGCTCCCTGGTGCTCGCCGAGACCTCGGCCGTGCTCGGCGGCCAGGAACCGCTCGACAGCGAAGGCACCCACACCTTCAAGGAGATGGGCATCAACTCGGTGAACGCCGTCGAGCTCCGCAACCGCCTCATCGCGGCCACGGACCTGCGGCTCCCCGCCACGCTCGTCTACGACCACCCCACCCCGAACGCGGTCGTCCGCCTCGTACGCGAACGCCTCGCGCGCCCGGCCACCGCCGCACGCGACGTGGACTCGGTCGTGGCCGAGCTGGAGTCCCTGCTCACGGCCGGCGCGGAGGTCTCGGCGGAGGCGGTGGCACGGCTGAAGGCGATGGCGGCGGGGCGGGACGGCACTACGGACACCGGTTCCGGCGGGCCCCTGGACCTGACGTCGGCCAGCGACGAGGACCTGTTCCGGCTGATGGACGCGGAGCACTGA	MPVHTADYVIQPPTDAAEVRGGHTLPEVFETASRAAPDAVAIVDGDRSRTWAQWRADVRALARGLQESGVGPGDVVAVRLPNSWEFQTLHLAVAAVGAVLLPVHEGTPTAEVHALLTRAEPVLLVLSASGSEGTATARSLLESVPTLRGVLLAGASEAECEEPGIGALDGLRAAWTGSEPRPVHLTPDMPLALIPSSGTTSARPKLCVHTHGGLLANTAAVVADAADAFGGTVLTACPMTHLFGLQSLHTALFAARTQVLLTGWDVDRFLELAREHNPRVVFAVPAQLRDIVARLARAGEPAGFAPHQVRTAGAALAPALAAQIRAALDCEPVVVWGMSEIGTGTATRAHHPDGSVGEPVDGVRVRVVDEHGAECAAGETGELQYQGPAMFRGYFREPELTRSALTDDGWLRTGDIAAIDADGVVVLHGRAAEVIATGGRKFGATEIESLLAELAGLGPLAVAGAPDDRLGEYPCLVVTDRADRTIGLTEVTAFLRRRGLADHKIPLELVTVRELPFTPAGKLDRRALKEQLRTGLEATPVAARLGAVPPETAEEALELVRDCVGQVLGSSGDPAGPAVGAPEFPDTEFRRLGLDSVLAVRLRNLLREETGLSLPVTLAFDFPTPRAVAHALAEQNDPASAAASGKTAEEARRFPADEADPVAIVAMACRLPGGADSPDALWELLAGGTDAMRPFPDDRGWDLDRLFDEDPDRPGTCYAREGGFLPGAGDFDAGFFGLSDHEATATDPQQRLLLVAAWETFERAGIDPASLKGTRTGVFTGAMERGYGALASAVPSEWESTLTTGAANSAISGRIAYTYGLEGPALTVDTASSSSLVALHLACRSLRSGETDLALAGGVTVMATPAPFTHFARLRALATDSRAKAYADTANGSAWAEGAGLLLLERLSDARRNGHRVLALVRGSAVNQDGASNGLTAPSGPAQQRVIRQALADAGLTPRDVDAVEGHGTGTPLGDPIEAQALMATYGQERPEGRPLWLGSVKSNLGHTQAAAGVVGVIKTVLALGRGVLPRTLHVETPSTKVDWSAGAVRLLTEAQPWPQESGHTRRAGVSSFGLTGTNAHVILEEAPDGTQSAPGSEPADDTAVPWVLSARSRTALREQARRLAEHVTAHPGLRTQDIAHALATTRTRHRHRAVVSGSDRDRMLSATAAFGRGERAADVTPLDSAPGGLAFVFSGQGGQHPGMGRGAAEAFPVFGEALREVCDTLDPLLARPLTSVMWADADSEEATLLHNAEFSQPSLFALQVALYRLYESWGMAPDRLAGHSAGEIAAAHVTGILTLQDACALVASRGRLISSLPVGGATVAVRISEDEVRGWLAEETTGSVSIAAVNGPHSLVLSGAEAPLIALTDRLRDAGHKTHRIPMRVAAHSPLMDPILGEFRAVVRTLAYGTPTIPLVSTVTGRPLTDEEARDPEHWVRHVRRPVRFKDAIGRLREERVTGFLELGAEPLLTPMIDECLEAAGPQHGTAVVPSLSSGVPDRQILLSAAARVHTHGAPVDWDAVLPGARPVDLPTYAFQRRRFWLAAGPGAAAEAGFVGAAIGAGAPAADAEEPSGLEARLAGLEDAEQDAYVRSLVLAETSAVLGGQEPLDSEGTHTFKEMGINSVNAVELRNRLIAATDLRLPATLVYDHPTPNAVVRLVRERLARPATAARDVDSVVAELESLLTAGAEVSAEAVARLKAMAAGRDGTTDTGSGGPLDLTSASDEDLFRLMDAEH	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	312.23	gnl|BL_ORD_ID|4935|hsp_num:0	5928			825	1641	colistin A; colistin B
BGC0000138.1|Rimocidin_11 # 18149 # 18550 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000138.1|Rimocidin_11 	18149	18550	-	Loose	300	33.4982	SAT-4	25.0	3002897	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGGCGATCACGTACGAGTGGCGGGGCGACTTCGAGAACGCGGCCGTCAACCGGCTGCACGCGGAGGGCTTCGGCCACCGGGGCCTGGACATCGACTGGGTGGCGCAGGTCCACCGGCACAGTCTCGGCTGGGTGTGCGCCCGGCGCGACCGTGACGGTGAACTCGTCGGCTTCGTCAATGTCGCGTGGGACGGTGGTGTCCACGCGTTCGTCCTGGACACCGTGGTGACGGCGGACATGCGCCGTTCCGGGATCGGTGCCGGGCTGGTCGCCGCGGCCGTCGGGGGCGCCCGGGCGGCGCGGTGCGAATGGCTGCACGTCGACTTCGACGACGAACTGCGCACGTTCTACTTCGACGCCTGCGGGTTCCAGCCGACGAACGCGGGTCTCATCGCACTCTGA	MAITYEWRGDFENAAVNRLHAEGFGHRGLDIDWVAQVHRHSLGWVCARRDRDGELVGFVNVAWDGGVHAFVLDTVVTADMRRSGIGAGLVAAAVGGARAARCEWLHVDFDDELRTFYFDACGFQPTNAGLIAL	MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF	73.89	gnl|BL_ORD_ID|1483|hsp_num:0	1505			234	462	streptothricin
BGC0000138.1|Rimocidin_12 # 18593 # 19054 # 1 # ID=1_12;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000138.1|Rimocidin_12 	18593	19054	+	Loose	2000	28.4906	adeJ	28.3	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCGCATGGCCGAGCTTGTCGCAACGTCCGTCGGTGGCACACCGATCACGGCCCTCGACGACGGCGAAGGACCGCCGCTGCTCCTCGTGCACGGGGGCGGTGGCGGCACCGCGTCCTGGGACGGCGTCATACGGTCGCTGGCCGACGGCTTCCGGGTGGTCAGGATCGCCCGCCGTATCTACGTCCCCGGGGCGACGACCCCGCCGTACTACTCGACGGCCGTCGAAGCGGCGGACATTCTGGCGATCGCCGGGCTCCTCGGCCGGCCCCCGCTGCTGGCCGGTCACTCCTCGGGCGCGGTCGCCGCGCTCGAAGCGGCGGTGCGTGCGCCCGAGGCACTGGCGGGCCTGTTCCTCTACGAACCGCCGGTGTCCACCCGGTCCCTGGCCGGAGGGGAGGCGGCCCGGCGCGCCCGTGCGGCGTTCGAGGCGGGAGACGCCCGCGAGGCGATGCGGATC	MVRMAELVATSVGGTPITALDDGEGPPLLLVHGGGGGTASWDGVIRSLADGFRVVRIARRIYVPGATTPPYYSTAVEAADILAIAGLLGRPPLLAGHSSGAVAALEAAVRAPEALAGLFLYEPPVSTRSLAGGEAARRARAAFEAGDAREAMRI	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	14.56	gnl|BL_ORD_ID|574|hsp_num:0	630			594	753	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000138.1|Rimocidin_10 # 16497 # 17843 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000138.1|Rimocidin_10 	16497	17843	-	Loose	660	38.891	MexS	27.63	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATACTGAACGCTATTCAGGCGCCGGACACCACGGCCGCCGACTTCGCCGCGCTGCCGCTGCCCGAGTCGTACCGCGCGATCACCGTCCACAAGGACGAGACCGACATGTTCGAGGGGCTCGCGGGGTGCGACAAGGACCCGCGCAAGTCGCTGCACCTCGACGAGGTGGCCGTCCCCGAACTCGGTCCCGGCGAGGCCCTGGTGGCCGTCATGGCGTCCTCGGTGAACTACAACAGCGTCTGGACCTCGATCTTCGAGCCGCTGCCGACGTTCGGGTTCCTGGAGCGGTACGGCCGGCGCAGCGAGCTCGCCAAGCGGCACGACCTGCCGTACCACGTCATCGGCTCCGACCTGGCGGGCGTCGTGCTGCGCACCGGGCCCGGCGTCACCGTCTGGAAGCCCGGTGACGAGGTCGTCGCGCACTGCCTGTCCGTCGAGCTGGAGAGCGCGGACGGCCACGGTGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACCAATTTCGGCGGTCTCGCCGAACTCGCGCTGGTGAAGTCGAATCAGCTGATGCCCAAGCCCGGCCATCTCACGTGGGAGGAGGCGGCGGCCTCCGGGCTGGTGAATTCCACCGCGTACCGCCAGCTGGTGTCCCGCAACGGCGCGGGCATGAAGGTCGGTGACAATGTGCTGATCTGGGGCGCGAGCGGCGGACTCGGTTCGTACGCGACGCAGTTGGTGCTGGCCGGCGGCGGCACACCCGTCTGTGTGGTGTCCAACGACCAGAAGGCGGAGATCTGCCGGTCCATGGGCGCGGAAGCGGTCATCGACCGCAACGCCGAGGGGTACCGGTTCTGGAAGGACGAGCAGACGCAGGACCCCCGGGAGTGGAAGCGGTTCGGCAAGCGCATCCGCGAGCTGACCGGCGGCGAGGACGTGGACATCGTTTTCGAGCACCCGGGGCGGGAGACGTTCGGCGCGAGTGTGTTCGTCACGCGCAAGGGCGGCACGGTCGTCACCTGCGCCTCCACCTCGGGCTACCAGCACCAGTACGACAACCGCTATCTGTGGATGTCGCTCAAGCGCATCGTGGGCTCGCACTTCGCCAACTACCGCGAGGCGTGGGAGGCCAACCGCCTGATCGCCAAGGGCAGGATCCACCCGACGCTGTCCCAGACCTACCCCCTGAGGGAGACCGGGCAGGCGGCGTACGACGTGCACCGCAACCTCCACCAGGGCAAGGTCGGCATTCTGGCGCTCGCTCCCGAGGAAGGACTCGGCGTACGGGACGCCGAGTTCCGGGCGCGGCACGCCAGCGCCATCAACCGCTTCCGCGGGACGCTGGAGGACTGA	VKEILNAIQAPDTTAADFAALPLPESYRAITVHKDETDMFEGLAGCDKDPRKSLHLDEVAVPELGPGEALVAVMASSVNYNSVWTSIFEPLPTFGFLERYGRRSELAKRHDLPYHVIGSDLAGVVLRTGPGVTVWKPGDEVVAHCLSVELESADGHGDTMLDPEQRIWGFETNFGGLAELALVKSNQLMPKPGHLTWEEAAASGLVNSTAYRQLVSRNGAGMKVGDNVLIWGASGGLGSYATQLVLAGGGTPVCVVSNDQKAEICRSMGAEAVIDRNAEGYRFWKDEQTQDPREWKRFGKRIRELTGGEDVDIVFEHPGRETFGASVFVTRKGGTVVTCASTSGYQHQYDNRYLWMSLKRIVGSHFANYREAWEANRLIAKGRIHPTLSQTYPLRETGQAAYDVHRNLHQGKVGILALAPEEGLGVRDAEFRARHASAINRFRGTLED	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	132.15	gnl|BL_ORD_ID|1039|hsp_num:0	1041			33	585	ciprofloxacin; trimethoprim; chloramphenicol
